A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

NCT00754988 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

666

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Metformin
DRUG: Placebo (matching sitagliptin)
DRUG: Placebo (matching taspoglutide)
DRUG: Sitagliptin
DRUG: Taspoglutide

Sponsor

Hoffmann-La Roche